{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:15:06Z","timestamp":1783624506200,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Health and Medical Research Council Investigator Grant","award":["2041822"],"award-info":[{"award-number":["2041822"]}]},{"name":"Australian Research Council Discovery Early Career Researcher Award","award":["#DE250101115"],"award-info":[{"award-number":["#DE250101115"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alcohol is commonly used alongside anabolic-androgenic steroids (AAS), yet its relationship with mental health in this population remains poorly understood. Among people reporting recent AAS use, hazardous drinkers reported higher prevalence of multiple psychiatric diagnoses than low-risk drinkers, particularly mood, anxiety, trauma-related, and psychotic conditions. These associations remained after adjustment for past 12-month use of other drugs beyond alcohol and AAS. Alcohol-risk level may therefore help identify AAS consumers who require more comprehensive mental health assessment.<\/jats:p>","DOI":"10.1093\/alcalc\/agag047","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:04:33Z","timestamp":1783623873000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical mental health diagnoses among anabolic-androgenic steroid consumers classified as low-risk or hazardous drinkers: a brief report"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8759-2101","authenticated-orcid":false,"given":"Benjamin","family":"Bonenti","sequence":"first","affiliation":[{"name":"School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Level 2, Public Health Building (Building 887), 288 Herston Road, Herston, QLD 4006,","place":["Australia"]},{"name":"School of Applied Psychology, Griffith University, Level 7, Ian O'Connor Building (G40) , Parklands Drive, Southport, QLD 4222,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-9772","authenticated-orcid":false,"given":"Cheneal","family":"Pulj\u00e9vic","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Level 2, Public Health Building (Building 887), 288 Herston Road, Herston, QLD 4006,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-0173","authenticated-orcid":false,"given":"Jason","family":"Ferris","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Level 2, Public Health Building (Building 887), 288 Herston Road, Herston, QLD 4006,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-3276","authenticated-orcid":false,"given":"Emma","family":"Davies","sequence":"additional","affiliation":[{"name":"Centre for Psychological Research, School of Psychology, Social Work and Public Health, Oxford Brookes University , Headington Campus, Gipsy Lane, Headington, Oxford, OX3 0BP,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Winstock","sequence":"additional","affiliation":[{"name":"University College London , Gower Street, London, WC1E 6BT,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian W","family":"Shorter","sequence":"additional","affiliation":[{"name":"School of Psychology, Queen\u2019s University Belfast, David Keir Building , 18\u201330 Malone Road, Belfast, BT9 5BN,","place":["United Kingdom"]},{"name":"Research Group on Treatment and Addiction, Tampere University , Linna Building, Kalevantie 5, FI-33014 Tampere University, Tampere,","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Ganson","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Level 2, Public Health Building (Building 887), 288 Herston Road, Herston, QLD 4006,","place":["Australia"]},{"name":"Factor-Inwentash Faculty of Social Work, University of Toronto , 246 Bloor Street West, Toronto, ON M5S 1V4,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Barnett","sequence":"additional","affiliation":[{"name":"School of Psychology, The University of Queensland, Level 3, McElwain Building (Building 24A) , St Lucia, QLD 4072,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6541-0604","authenticated-orcid":false,"given":"Jason M","family":"Nagata","sequence":"additional","affiliation":[{"name":"Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California San Francisco , 550 16th Street, Fourth Floor, San Francisco, CA 94143-0503,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-0266","authenticated-orcid":false,"given":"Timothy","family":"Piatkowski","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Level 2, Public Health Building (Building 887) , 288 Herston Road, Herston, QLD 4006,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2026070915042914400_ref1","doi-asserted-by":"crossref","first-page":"1178646917753422","DOI":"10.1177\/1178646917753422","article-title":"Modulation of tryptophan and serotonin metabolism as a biochemical basis of the Behavioral effects of use and withdrawal of androgenic-anabolic steroids and other image-and performance-enhancing agents","volume":"11","author":"Badawy","year":"2018","journal-title":"Int J Tryptophan Res"},{"key":"2026070915042914400_ref2","article-title":"A case of acute psychosis triggered by anabolic steroid abuse. Endocrine abstracts","volume":"90","author":"Bey","year":"2023","journal-title":"Bioscientifica."},{"key":"2026070915042914400_ref3","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metabol"},{"key":"2026070915042914400_ref4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1360-0443.2010.03351.x","article-title":"Alcohol and depression","volume":"106","author":"Boden","year":"2011","journal-title":"Addiction"},{"key":"2026070915042914400_ref5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1249\/JSR.0000000000000917","article-title":"Bipolar disorder and athletes: a narrative review","volume":"20","author":"Daley","year":"2021","journal-title":"Curr Sports Med Rep"},{"key":"2026070915042914400_ref6","first-page":"100543","article-title":"Transdiagnosis of alcohol use and psychopathologies: a systematic review","volume":"19","author":"De Aguiar","year":"2024","journal-title":"Addict Behav Rep"},{"key":"2026070915042914400_ref7","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1016\/S2214-109X(23)00057-8","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review","volume":"11","author":"Degenhardt","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2026070915042914400_ref8","doi-asserted-by":"crossref","first-page":"1218737","DOI":"10.3389\/fncir.2023.1218737","article-title":"GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential","volume":"17","author":"Dharavath","year":"2023","journal-title":"Front Neural Circuits"},{"key":"2026070915042914400_ref9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/1403494820973096","article-title":"Prevalence, mental health and substance use of anabolic steroid users: a population-based study on young individuals","volume":"49","author":"Gestsdottir","year":"2021","journal-title":"Scand J Public Health"},{"key":"2026070915042914400_ref10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1249\/MSS.0000000000002852","article-title":"Anabolic steroids use is associated with impairments In atrial and ventricular cardiac structure and performance In athletes","volume":"54","author":"Grandperrin","year":"2021","journal-title":"Med Sci Sports Exerc"},{"key":"2026070915042914400_ref11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000333037","article-title":"Anabolic androgenic steroids In the general population: user characteristics and associations with substance use","volume":"18","author":"Hakansson","year":"2012","journal-title":"Eur Addict Res"},{"key":"2026070915042914400_ref12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2015.03.003","article-title":"Combined effects of androgen anabolic steroids and physical activity on the hypothalamic\u2013pituitary\u2013gonadal axis","volume":"150","author":"Hengevoss","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026070915042914400_ref13","volume-title":"IBM SPSS Statistics for Windows (Version 30.0)","author":"IBM","year":"2024"},{"key":"2026070915042914400_ref14","doi-asserted-by":"crossref","first-page":"2337717","DOI":"10.1080\/07853890.2024.2337717","article-title":"Anabolic-androgenic steroids are linked to depression and anxiety In male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids","volume":"56","author":"Karagun","year":"2024","journal-title":"Ann Med"},{"key":"2026070915042914400_ref15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","article-title":"Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review","volume":"13","author":"Piacentino","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"2026070915042914400_ref16","doi-asserted-by":"crossref","first-page":"100197","DOI":"10.1016\/j.peh.2021.100197","article-title":"Exploring the harms arising from polysubstance use among performance and image enhancing drug users among young Australian men","volume":"9","author":"Piatkowski","year":"2021","journal-title":"Performance Enhancement Health"},{"key":"2026070915042914400_ref17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12954-024-00972-5","article-title":"Exploring the role of community pharmacies As a harm reduction environment for anabolic\u2013androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists","volume":"21","author":"Piatkowski","year":"2024","journal-title":"Harm Reduct J"},{"key":"2026070915042914400_ref18","doi-asserted-by":"crossref","DOI":"10.1111\/add.70395","article-title":"What anabolic\u2013androgenic steroids reveal about the limits of current harm reduction models","author":"Piatkowski","year":"2026","journal-title":"Addiction."},{"key":"2026070915042914400_ref19","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1176\/ajp.145.4.487","article-title":"Affective and psychotic symptoms associated with anabolic steroid use","volume":"145","author":"Pope","year":"1988","journal-title":"Am J Psychiatry"},{"key":"2026070915042914400_ref20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use: a controlled study of 160 athletes","volume":"51","author":"Pope","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"2026070915042914400_ref21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (Audit): who collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"2026070915042914400_ref22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000199045","article-title":"Multisubstance use as a feature of addiction to anabolic-androgenic steroids","volume":"15","author":"Skarberg","year":"2009","journal-title":"Eur Addict Res"},{"key":"2026070915042914400_ref23","first-page":"837","article-title":"Transdiagnostic mood, anxiety, and trauma symptom factors in alcohol use disorder: neural correlates across 3 brain networks","volume":"9","author":"Tenekedjieva","year":"2024","journal-title":"Biol Psychiatry: Cognit Neurosci Neuroimaging"},{"key":"2026070915042914400_ref24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2009.08.043","article-title":"Frontal\u2013striatal abnormalities underlying behaviours in the compulsive\u2013impulsive spectrum","volume":"289","author":"Van Den Heuvel","year":"2010","journal-title":"J Neurol Sci"},{"key":"2026070915042914400_ref25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.20882\/adicciones.5","article-title":"Physiological and psychological effects of a high dose of alcohol in young men and women","volume":"26","author":"Vinader-Caerols","year":"2014","journal-title":"Adicciones"},{"key":"2026070915042914400_ref26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2018.02.022","article-title":"Identifying a typology of men who use anabolic androgenic steroids (AAS)","volume":"55","author":"Zahnow","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/61\/4\/agag047\/68740894\/agag047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/61\/4\/agag047\/68740894\/agag047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:04:37Z","timestamp":1783623877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/alcalc\/article\/doi\/10.1093\/alcalc\/agag047\/8729323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,13]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agag047","relation":{},"ISSN":["0735-0414","1464-3502"],"issn-type":[{"value":"0735-0414","type":"print"},{"value":"1464-3502","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,5,13]]},"article-number":"agag047"}}